The Jonsson Comprehensive Cancer Center (JCCC) is a cancer research center at University of California, Los Angeles.
History The center was originated by UCLA scientists and volunteers who began working together in the late 1960s.Jonsson Comprehensive Cancer Center: University of California at Los Angeles, Los Angeles, California, National Cancer Institute (accessed August 22, 2016). The center was formally established in 1974 and was designated as a comprehensive cancer center by the National Cancer Institute in 1976.Anne Hubell, "University of California, Los Angeles, Jonsson Comprehensive Cancer Center" in The SAGE Encyclopedia of Cancer and Society (SAGE Publications: 2d ed. 2015; ed. Graham A. Colditz), pp. 1228-29. The namesake of the center is the Jonsson family; entrepreneur and philanthropist Kenneth Alan Jonsson (the son of Texas Instruments co-founder J. Erik Jonsson), along with his wife Diana Gordon Jonsson, made a $1 million gift for UCLA in 1975 to establish the center, and continued to financially support the center over a period of decades.Obituary: Kenneth Alan Jonsson dies at 79; co-founder of cancer center at UCLA, Los Angeles Times (April 4, 2010).Mary Rourke, Diana G. Jonsson, 76; Helped Found Prominent Cancer Center at UCLA, Los Angeles Times (May 12, 2006).
Joseph W. Cullen served as a deputy director of the center.Obituary: Joseph W. Cullen, 53, a Cancer Researcher, New York Times (November 28, 1990).
Organization, activities, and funding The primary sponsor of the center is the Jonsson Cancer Center Foundation (JCCF), a 501(c)(3) entity (established in 1945).About the Jonsson Cancer Center Foundation, Jonsson Comprehensive Cancer Center (accessed August 22, 2016).
The center employs over 500 physicians and scientists, who engage in clinical activities (i.e., cancer treatment), education, research (basic and clinical), and cancer prevention.
Although based at UCLA, the center has clinics elsewhere in California, in Westwood, Santa Monica, Alhambra, Irvine, Pasadena, Porter Ranch, Santa Clarita, and Simi Valley.
The center is known for its research on breast and ovarian cancer. JCCC scientists developed palbociclib (PD 0332991), a breast-cancer drug that was in phase III clinical trials as of 2015. JCCC scientists also identified IGF-1 as a pathway as one pathway for the growth of tumors.
In 2013, U.S. News & World Report ranked JCCC as #11 nationally among cancer centers. In 2015, the center ranked #6.UCLA's Jonsson Comprehensive Cancer Center once again ranks among top 10 cancer centers nationwide (press release), Jonsson Comprehensive Cancer Center (July 21, 2015).
In 2023, U.S. News & World Report ranked JCCC #4 nationally and #1 in California among cancer centers.
References
External links